original ) (raw )Nuclear factor kappa B inhibition improves conductance artery function in type 2 diabetic mice
Khalid Matrougui
Diabetes/Metabolism Research and Reviews, 2014
View PDFchevron_right
Hyperglycemia-induced activation of nuclear transcription factor kappaB in vascular smooth muscle cells
Bobby Khan
Diabetes, 1999
View PDFchevron_right
Enhanced NF-κB Activity Impairs Vascular Function Through PARP-1–, SP-1–, and COX-2–Dependent Mechanisms in Type 2 Diabetes
María Galán
Diabetes, 2013
View PDFchevron_right
Endothelial Cell-Specific NF-κB Inhibition Protects Mice from Atherosclerosis
Apostolos Polykratis
Cell Metabolism, 2008
View PDFchevron_right
The NF-kappa B signal transduction pathway in aortic endothelial cells is primed for activation in regions predisposed to atherosclerotic lesion formation
Myron Cybulsky
Proceedings of the National Academy of Sciences, 2000
View PDFchevron_right
Activation of NF-E2-Related Factor-2 Reverses Biochemical Dysfunction of Endothelial Cells Induced by Hyperglycemia Linked to Vascular Disease
Antonysunil Adaikalakoteswari
Diabetes, 2008
View PDFchevron_right
Blockade of the Nuclear Factor-κB Pathway in the Endothelium Prevents Insulin Resistance and Prolongs Life Spans
Tatsuo Shimosawa
Circulation, 2012
View PDFchevron_right
Adaptive induction of NF-E2-related factor-2-driven antioxidant genes in endothelial cells in response to hyperglycemia
Rosario Jimenez
American Journal of Physiology-Heart and Circulatory Physiology, 2011
View PDFchevron_right
Beta Adrenergic Receptors Stimulation Attenuates Phosphorylation of NF-κB and IκBα in Hyperglycemic Endothelial Cells
Gracie Ong Yan
Cellular Physiology and Biochemistry
View PDFchevron_right
Role of nuclear factor-kappaB in a rat model of vascular injury
Angela Ianaro
Naunyn-Schmiedeberg's archives of pharmacology, 2001
View PDFchevron_right
Blockade of the Nuclear Factor- B Pathway in the Endothelium Prevents Insulin Resistance and Prolongs Life Spans
Gabriel Cordeiro
Circulation, 2012
View PDFchevron_right
Diabetes-associated sustained activation of the transcription factor nuclear factor-κB
Ingrid Kloting
Diabetes, 2001
View PDFchevron_right
Role of NF-κB in the pathogenesis of diabetes and its associated complications
Dev Dass Santani
Pharmacological Reports, 2009
View PDFchevron_right
Diabetes Induced Renal Complications by Leukocyte Activation of Nuclear Factor κ-B and its Regulated Genes Expression
Noura Darwish
2020
View PDFchevron_right
Potential Role of Nuclear Factor 𝜿B in Diabetic Cardiomyopathy
José Tuñón
Mediators of Inflammation, 2011
View PDFchevron_right
The nuclear factor (erythroid-derived 2)-like 2 (Nrf2) activator dh404 protects against diabetes-induced endothelial dysfunction
Judy Haan
Cardiovascular diabetology, 2017
View PDFchevron_right
Nuclear Factor-{Kappa} B Contributes to Infarction After Permanent Focal Ischemia
Antti Nurmi
Stroke, 2004
View PDFchevron_right
Vascular inflammation, insulin resistance, and endothelial dysfunction in salt-sensitive hypertension: role of nuclear factor kappa B activation
Ivonne Schulman
Journal of Hypertension, 2010
View PDFchevron_right
Nuclear factor kappa-B and the heart
Zhong-qun Yan
Journal of the American College of Cardiology, 2001
View PDFchevron_right
Hyperinsulinemia Enhances Transcriptional Activity of Nuclear Factor! B Induced by Angiotensin II, Hyperglycemia, and Advanced Glycosylation End Products in Vascular Smooth Muscle Cells
Boris Draznin
2000
View PDFchevron_right
Vascular Endothelial Cell–Specific NF-κB Suppression Attenuates Hypertension-Induced Renal Damage
Carlos Alcantara Estrada
Circulation Research, 2007
View PDFchevron_right
Hyperglycemia reduces nitric oxide synthase and glycogen synthase activity in endothelial cells
Aliza Stark
Nitric Oxide, 2002
View PDFchevron_right
Nuclear Transcription Factor Kappa B (NF-кB) and Molecular Damage Mechanisms in Acute Cardiovascular Diseases. A Review
Virgiliu Sorop
Journal Of Cardiovascular Emergencies, 2018
View PDFchevron_right
Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB): a new potential therapeutic target in atherosclerosis?
Andrzej Kułach
Pharmacological Reports, 2010
View PDFchevron_right
NF-κB — A Key Factor in Atherogenesis and Atheroprogression
Gaia Favero
Thrombosis, Atherosclerosis and Atherothrombosis - New Insights and Experimental Protocols, 2015
View PDFchevron_right
Rosiglitazone attenuates NF- B-mediated Nox4 upregulation in hyperglycemia-activated endothelial cells
R. Sutliff
AJP: Cell Physiology, 2012
View PDFchevron_right
A negative feedback mechanism involving nitric oxide and nuclear factor kappa-B modulates endothelial nitric oxide synthase transcription
I. Grumbach
Journal of Molecular and Cellular Cardiology, 2005
View PDFchevron_right
Hyperinsulinemia-induced KLF5 mediates endothelial angiogenic dysfunction in diabetic endothelial cells
chang you yan
Journal of Molecular Histology, 2019
View PDFchevron_right
Activation of nuclear factor-κB and its proinflammatory mediator cascade in the infarcted rat heart
Suzy Chen
Biochemical and Biophysical Research Communications, 2004
View PDFchevron_right
Secretory products from human adipocytes impair endothelial function via nuclear factor κB
Michael Stumvoll
Atherosclerosis, 2008
View PDFchevron_right
NF-kappa B Mediates alpha vbeta 3 Integrin-induced Endothelial Cell Survival
M. Scatena
The Journal of Cell Biology, 1998
View PDFchevron_right